| MeSH term | MeSH ID | Detail |
|---|---|---|
| Esophageal Neoplasms | D004938 | 20 associated lipids |
| Fasciitis | D005208 | 2 associated lipids |
| Femoral Neck Fractures | D005265 | 3 associated lipids |
| Gilbert Disease | D005878 | 2 associated lipids |
| Glucosephosphate Dehydrogenase Deficiency | D005955 | 5 associated lipids |
| Hearing Disorders | D006311 | 10 associated lipids |
| Heart Defects, Congenital | D006330 | 20 associated lipids |
| Heart Failure | D006333 | 36 associated lipids |
| Hemolysis | D006461 | 131 associated lipids |
| Hemosiderosis | D006486 | 1 associated lipids |
Glucaric acid
Glucaric acid is a lipid of Fatty Acyls (FA) class. Glucaric acid is associated with abnormalities such as Consumption-archaic term for TB and furuncle. The involved functions are known as Oxidation, Mutation, Process, Cell Growth and Anabolism. Glucaric acid often locates in BL21, Clone and host. The associated genes with Glucaric acid are MIOX gene, ISYNA1 gene, Genome and Candidate Disease Gene. The related experimental models are Knock-out.
Cross Reference
Introduction
To understand associated biological information of Glucaric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Glucaric acid?
Glucaric acid is suspected in and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Glucaric acid
PubChem Associated disorders and diseases
What pathways are associated with Glucaric acid
Lipid pathways are not clear in current pathway databases. We organized associated pathways with Glucaric acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Related references are published most in these journals:
| Pathway name | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Glucaric acid?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Glucaric acid?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Glucaric acid?
There are no associated biomedical information in the current reference collection.
What genes are associated with Glucaric acid?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Glucaric acid?
Knock-out
Knock-out are used in the study 'Evolution-guided optimization of biosynthetic pathways.' (Raman S et al., 2014).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with Glucaric acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Chaudhuri RR et al. | Complete genome sequence and comparative metabolic profiling of the prototypical enteroaggregative Escherichia coli strain 042. | 2010 | PLoS ONE | pmid:20098708 |
| Sienkiewicz-Porzucek A et al. | Mild reductions in mitochondrial NAD-dependent isocitrate dehydrogenase activity result in altered nitrate assimilation and pigmentation but do not impact growth. | 2010 | Mol Plant | pmid:20035036 |
| Dangsuwan P and Manchana T | Blood transfusion reduction with intravenous iron in gynecologic cancer patients receiving chemotherapy. | 2010 | Gynecol. Oncol. | pmid:20051288 |
| Garcia-Fernandez N et al. | Randomized clinical trial on acute effects of i.v. iron sucrose during haemodialysis. | 2010 | Nephrology (Carlton) | pmid:20470276 |
| Firoz BF et al. | Eosinophilic fasciitis secondary to intravenous iron infusions. | 2010 | Dermatol. Online J. | pmid:20492822 |
| Gupta A et al. | Response to iron sucrose in dialysis patients sensitive to iron dextran. | 2010 | Saudi J Kidney Dis Transpl | pmid:20587886 |
| Zhang ZW et al. | The plastid hexokinase pHXK: a node of convergence for sugar and plastid signals in Arabidopsis. | 2010 | FEBS Lett. | pmid:20650273 |
| Hedenus M and Birgegård G | The role of iron supplementation during epoietin treatment for cancer-related anemia. | 2009 | Med. Oncol. | pmid:18473194 |
| Costa S et al. | In vitro evaluation of the chemoprotective action mechanisms of leontopodic acid against aflatoxin B1 and deoxynivalenol-induced cell damage. | 2009 | J Appl Toxicol | pmid:18636399 |
| Kell DB | Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. | 2009 | BMC Med Genomics | pmid:19133145 |
| PERSOONIAL Reflections. | 2009 | Persoonia | pmid:20198167 | |
| Ginsberg G and Rice DC | Does rapid metabolism ensure negligible risk from bisphenol A? | 2009 | Environ. Health Perspect. | pmid:20049111 |
| Fior S and Gerola PD | Impact of ubiquitous inhibitors on the GUS gene reporter system: evidence from the model plants Arabidopsis, tobacco and rice and correction methods for quantitative assays of transgenic and endogenous GUS. | 2009 | Plant Methods | pmid:20042078 |
| Dong T and Schellhorn HE | Global effect of RpoS on gene expression in pathogenic Escherichia coli O157:H7 strain EDL933. | 2009 | BMC Genomics | pmid:19650909 |
| Barraclough KA et al. | Rationale and design of the oral HEMe iron polypeptide Against Treatment with Oral Controlled Release Iron Tablets trial for the correction of anaemia in peritoneal dialysis patients (HEMATOCRIT trial). | 2009 | BMC Nephrol | pmid:19635169 |
| Ibrahim HN et al. | Parenteral iron use: possible contribution to exceeding target hemoglobin in hemodialysis patients. | 2009 | Clin J Am Soc Nephrol | pmid:19211669 |
| Haddad A et al. | Use of iron sucrose in dialysis patients sensitive to iron dextran. | 2009 | Saudi J Kidney Dis Transpl | pmid:19237805 |
| Pollak VE et al. | The importance of iron in long-term survival of maintenance hemodialysis patients treated with epoetin-alfa and intravenous iron: analysis of 9.5 years of prospectively collected data. | 2009 | BMC Nephrol | pmid:19245700 |
| Torres-Corzo JG et al. | Comparison of cerebrospinal fluid obtained by ventricular endoscopy and by lumbar puncture in patients with hydrocephalus secondary to neurocysticercosis. | 2009 | Surg Neurol | pmid:19249584 |
| Clark SF | Iron deficiency anemia: diagnosis and management. | 2009 | Curr. Opin. Gastroenterol. | pmid:19262200 |
| Muñoz M et al. | [Usefulness of the administration of intravenous iron sucrose for the correction of preoperative anemia in major surgery patients]. | 2009 | Med Clin (Barc) | pmid:19264195 |
| Breborowicz A et al. | Intravenous iron sucrose changes the intraperitoneal homeostasis. | 2009 | Blood Purif. | pmid:19325240 |
| Gorder V et al. | Treatment of restless legs syndrome with iron infusion therapy. | 2009 | JAAPA | pmid:19354112 |
| De Saint-Hubert M et al. | Molecular imaging of cell death. | 2009 | Methods | pmid:19362149 |
| Kim YH et al. | Safety and usefulness of intravenous iron sucrose in the management of preoperative anemia in patients with menorrhagia: a phase IV, open-label, prospective, randomized study. | 2009 | Acta Haematol. | pmid:19332985 |
| Gehret TC et al. | Convenient large-scale synthesis of D-glucaro-1,4:6,3-dilactone. | 2009 | J. Org. Chem. | pmid:19777999 |
| Edwards TJ et al. | Randomized clinical trial of preoperative intravenous iron sucrose to reduce blood transfusion in anaemic patients after colorectal cancer surgery. | 2009 | Br J Surg | pmid:19731228 |
| Yoon SH et al. | Cloning and characterization of uronate dehydrogenases from two pseudomonads and Agrobacterium tumefaciens strain C58. | 2009 | J. Bacteriol. | pmid:19060141 |
| Moon TS et al. | Production of glucaric acid from a synthetic pathway in recombinant Escherichia coli. | 2009 | Appl. Environ. Microbiol. | pmid:19060162 |
| Luo Z et al. | Resistin induces insulin resistance by both AMPK-dependent and AMPK-independent mechanisms in HepG2 cells. | 2009 | Endocrine | pmid:19440859 |
| Grote L et al. | A randomized, double-blind, placebo controlled, multi-center study of intravenous iron sucrose and placebo in the treatment of restless legs syndrome. | 2009 | Mov. Disord. | pmid:19489063 |
| Kulnigg S et al. | Rapid recurrence of IBD-associated anemia and iron deficiency after intravenous iron sucrose and erythropoietin treatment. | 2009 | Am. J. Gastroenterol. | pmid:19491860 |
| Krafft A et al. | Selective use of recombinant human erythropoietin in pregnant patients with severe anemia or nonresponsive to iron sucrose alone. | 2009 | Fetal. Diagn. Ther. | pmid:19506383 |
| Asma S et al. | Safety, therapeutic effectiveness, and cost of parenteral iron therapy. | 2009 | Int. J. Hematol. | pmid:19495930 |
| GarcÃa-Erce JA et al. | Efficacy of preoperative recombinant human erythropoietin administration for reducing transfusion requirements in patients undergoing surgery for hip fracture repair. An observational cohort study. | 2009 | Vox Sang. | pmid:19497085 |
| Nguyen TV | Comparison of serum ferritin and transferrin saturation values associated with two i.v. iron formulations in hemodialysis patients. | 2009 | Am J Health Syst Pharm | pmid:19498125 |
| Fontés G et al. | Involvement of Per-Arnt-Sim Kinase and extracellular-regulated kinases-1/2 in palmitate inhibition of insulin gene expression in pancreatic beta-cells. | 2009 | Diabetes | pmid:19502418 |
| Shimizu Y et al. | Hypophosphatemia induced by intravenous administration of saccharated ferric oxide: another form of FGF23-related hypophosphatemia. | 2009 | Bone | pmid:19555782 |
| Li H and Wang SX | [Intravenous iron sucrose in maintenance dialysis patients with renal anemia: a clinical study]. | 2009 | Zhonghua Yi Xue Za Zhi | pmid:19567093 |
| Toblli JE et al. | Differences between original intravenous iron sucrose and iron sucrose similar preparations. | 2009 | Arzneimittelforschung | pmid:19517894 |
| Yi CX et al. | A major role for perifornical orexin neurons in the control of glucose metabolism in rats. | 2009 | Diabetes | pmid:19592616 |
| Dueber JE et al. | Synthetic protein scaffolds provide modular control over metabolic flux. | 2009 | Nat. Biotechnol. | pmid:19648908 |
| DeLisa MP and Conrado RJ | Synthetic metabolic pipelines. | 2009 | Nat. Biotechnol. | pmid:19668178 |
| Bencaiova G et al. | Iron prophylaxis in pregnancy: intravenous route versus oral route. | 2009 | Eur. J. Obstet. Gynecol. Reprod. Biol. | pmid:19406557 |
| Lindgren S et al. | Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: A randomized, controlled, evaluator-blind, multicentre study. | 2009 | Scand. J. Gastroenterol. | pmid:19330567 |
| ComÃn-Colet J et al. | A pilot evaluation of the long-term effect of combined therapy with intravenous iron sucrose and erythropoietin in elderly patients with advanced chronic heart failure and cardio-renal anemia syndrome: influence on neurohormonal activation and clinical outcomes. | 2009 | J. Card. Fail. | pmid:19879457 |
| Morimoto S et al. | Significance of urinary glucaric acid measurement and its application to paclitaxel therapy. | 2009 | Gan To Kagaku Ryoho | pmid:19920388 |
| Gambini JP et al. | Evaluation of patients with head and neck cancer by means of 99mTc-glucarate. | 2009 | J Nucl Med Technol | pmid:19949020 |
| Smith TG et al. | Effects of iron supplementation and depletion on hypoxic pulmonary hypertension: two randomized controlled trials. | 2009 | JAMA | pmid:19809026 |
| Muñoz M et al. | Intravenous iron in inflammatory bowel disease. | 2009 | World J. Gastroenterol. | pmid:19787830 |
| Zanor MI et al. | Metabolic characterization of loci affecting sensory attributes in tomato allows an assessment of the influence of the levels of primary metabolites and volatile organic contents. | 2009 | J. Exp. Bot. | pmid:19346240 |
| Gredilla E et al. | [Treating severe acute anemia due to vaginal bleeding in the Jehovah's Witness: a report of 2 cases]. | 2009 | Rev Esp Anestesiol Reanim | pmid:20151526 |
| Earley CJ et al. | A randomized, double-blind, placebo-controlled trial of intravenous iron sucrose in restless legs syndrome. | 2009 | Sleep Med. | pmid:18280205 |
| Vanin S et al. | Seasonal variation of trehalose and glycerol concentrations in winter snow-active insects. | 2008 Nov-Dec | Cryo Letters | pmid:19280052 |
| Usmanov RI et al. | Intravenous iron without erythropoietin for the treatment of iron deficiency anemia in patients with moderate to severe congestive heart failure and chronic kidney insufficiency. | 2008 Mar-Apr | J. Nephrol. | pmid:18446719 |
| Li H and Wang SX | Intravenous iron sucrose in peritoneal dialysis patients with renal anemia. | 2008 Mar-Apr | Perit Dial Int | pmid:18332450 |
| Nakamura Y et al. | Decreased valproate level caused by VPA-glucuronidase inhibition by carbapenem antibiotics. | 2008 | Drug Metab Lett | pmid:19356106 |
| Picker SM et al. | Effects of Mirasol PRT treatment on storage lesion development in plasma-stored apheresis-derived platelets compared to untreated and irradiated units. | 2008 | Transfusion | pmid:18513255 |
| Kuo KL et al. | Intravenous iron exacerbates oxidative DNA damage in peripheral blood lymphocytes in chronic hemodialysis patients. | 2008 | J. Am. Soc. Nephrol. | pmid:18495964 |
| Auerbach M and Ballard H | Intravenous iron in oncology. | 2008 | J Natl Compr Canc Netw | pmid:18597712 |
| Pinsk V et al. | Efficacy and safety of intravenous iron sucrose therapy in a group of children with iron deficiency anemia. | 2008 | Isr. Med. Assoc. J. | pmid:18605353 |
| Kaplinsky C | Parenteral iron therapy. | 2008 | Isr. Med. Assoc. J. | pmid:18605363 |
| Cuenca J et al. | Efficacy of intravenous iron sucrose administration for correcting preoperative anemia in patients scheduled for major orthopedic surgery. | 2008 | Anesthesiology | pmid:18580186 |
| Zółtaszek R et al. | [The biological role of D-glucaric acid and its derivatives: potential use in medicine]. | 2008 | Postepy Hig Med Dosw (Online) | pmid:18772850 |
| Stefánsson BV et al. | Ascorbyl free radical reflects catalytically active iron after intravenous iron saccharate injection. | 2008 | Free Radic. Biol. Med. | pmid:18775775 |
| Oleson L and Court MH | Effect of the beta-glucuronidase inhibitor saccharolactone on glucuronidation by human tissue microsomes and recombinant UDP-glucuronosyltransferases. | 2008 | J. Pharm. Pharmacol. | pmid:18718121 |
| Aghaie A et al. | New insights into the alternative D-glucarate degradation pathway. | 2008 | J. Biol. Chem. | pmid:18364348 |
| Al-Saran KA and Sabry AA | Pregnancy in dialysis patients: a case series. | 2008 | J Med Case Rep | pmid:18205953 |
| Bolaños L et al. | Intravenous iron sucrose does not impair sonographic brachial vasodilation in peritoneal dialysis patients. | 2008 | Adv Perit Dial | pmid:18986009 |
| Gonçalves P et al. | The effect of high glucose on SERT, the human plasmalemmal serotonin transporter. | 2008 | Nutr Neurosci | pmid:19000377 |
| Anirban G et al. | The comparative safety of various intravenous iron preparations in chronic kidney disease patients. | 2008 | Ren Fail | pmid:18661414 |
| Wang S et al. | Chemical reactions of vitamin C with intravenous-iron formulations. | 2008 | Nephrol. Dial. Transplant. | pmid:17951305 |
| Saluk-Juszczak J et al. | Protective effects of D-glucaro-1,4-lactone against oxidative modifications in blood platelets. | 2008 | Nutr Metab Cardiovasc Dis | pmid:17933501 |
| Teschke O et al. | Quorum sensing detected by atomic force microscopy imaging of corrals surrounding multicellular arrangement of bacteria. | 2008 | Microsc. Res. Tech. | pmid:17943987 |
| Roth S et al. | Comparative toxicity and cell-tissue distribution study on nanoparticular iron complexes using avian embryos and HepG2-cells. | 2008 | Transl Res | pmid:18061126 |
| Liu Z et al. | Evaluating the protective role of ischaemic preconditioning in rat hearts using a stationary small-animal SPECT imager and 99mTc-glucarate. | 2008 | Nucl Med Commun | pmid:18094633 |
| Wall GC and Pauly RA | Evaluation of total-dose iron sucrose infusions in patients with iron deficiency anemia. | 2008 | Am J Health Syst Pharm | pmid:18192261 |
| Li H and Wang SX | Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia. | 2008 | Blood Purif. | pmid:18212498 |
| Hasegawa K et al. | [Improvement of urinary d-glucaric acid assay and its application]. | 2008 | Yakugaku Zasshi | pmid:18176065 |
| Jaber BL | Iron sucrose causes greater proteinuria than ferric gluconate in non-dialysis chronic kidney disease. | 2008 | Kidney Int. | pmid:18235527 |
| Olas B et al. | D-glucaro 1,4-lactone and resveratrol as antioxidants in blood platelets. | 2008 | Cell Biol. Toxicol. | pmid:17846905 |
| Perek N et al. | Could 99mTc-glucarate be used to evaluate tumour necrosis? In vitro and in vivo studies in leukaemic tumour cell line U937. | 2008 | Eur. J. Nucl. Med. Mol. Imaging | pmid:18338166 |
| Lim R et al. | A permanent tan from iron. | 2008 | Kidney Int. | pmid:18340355 |
| Auerbach M et al. | The role of intravenous iron in anemia management and transfusion avoidance. | 2008 | Transfusion | pmid:18346021 |
| Auerbach M and Al Talib K | Low-molecular weight iron dextran and iron sucrose have similar comparative safety profiles in chronic kidney disease. | 2008 | Kidney Int. | pmid:18274543 |
| Lord RS and Bralley JA | Clinical applications of urinary organic acids. Part I: Detoxification markers. | 2008 | Altern Med Rev | pmid:18950247 |
| Tryfinopoulou P et al. | Diversity of Shewanella population in fish Sparus aurata harvested in the Aegean Sea. | 2007 | J. Appl. Microbiol. | pmid:17714405 |
| Vindal V et al. | GntR family of regulators in Mycobacterium smegmatis: a sequence and structure based characterization. | 2007 | BMC Genomics | pmid:17714599 |
| Beck-da-Silva L et al. | Rationale and design of the IRON-HF study: a randomized trial to assess the effects of iron supplementation in heart failure patients with anemia. | 2007 | J. Card. Fail. | pmid:17338998 |
| Sane R et al. | Safe administration of iron sucrose in a patient with a previous hypersensitivity reaction to ferric gluconate. | 2007 | Pharmacotherapy | pmid:17381390 |
| Breymann C et al. | Milk iron content in breast-feeding mothers after administration of intravenous iron sucrose complex. | 2007 | J Perinat Med | pmid:17302514 |
| Breborowicz A et al. | Peritoneal effects of intravenous iron sucrose administration in rats. | 2007 | Transl Res | pmid:17543848 |
| Sav T et al. | Is there a difference between the allergic potencies of the iron sucrose and low molecular weight iron dextran? | 2007 | Ren Fail | pmid:17497463 |
| Pai AB et al. | Comparison of oxidative stress markers after intravenous administration of iron dextran, sodium ferric gluconate, and iron sucrose in patients undergoing hemodialysis. | 2007 | Pharmacotherapy | pmid:17316146 |
| Vikrant S | Optimum dosage regimen for iron sucrose. | 2007 | Kidney Int. | pmid:17625585 |
| Reed J et al. | The safety of intravenous iron sucrose use in the elderly patient. | 2007 | Consult Pharm | pmid:17658969 |
| Auerbach M and Rodgers GM | Intravenous iron. | 2007 | N. Engl. J. Med. | pmid:17611217 |
| Agarwal R et al. | Iron sucrose causes greater proteinuria than ferric gluconate in non-dialysis chronic kidney disease. | 2007 | Kidney Int. | pmid:17622274 |
| Marsillach J et al. | Administration of exogenous erythropoietin beta affects lipid peroxidation and serum paraoxonase-1 activity and concentration in predialysis patients with chronic renal disease and anaemia. | 2007 | Clin. Exp. Pharmacol. Physiol. | pmid:17324148 |
| George P et al. | Coronary artery vasospasm with iron sucrose. | 2007 | Nephrol. Dial. Transplant. | pmid:17327282 |